https://www.news-medical.net/news/2009/03/11/46787.aspx
Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint
Jun 20, 2019 - Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients...
lupus nephritisstudyrituxanrituximabmisses
https://www.lulu.com/shop/j-king/bits-pieces-you-mightve-missed-about-your-lupus-nephritis/ebook/product-84zyq78.html
Lupus Nephritis J King Method
Years of endurance, sharp determination, and a unique physical approach have enabled J King to reveal powerful insights into autoimmune disease. Through...
lupus nephritisjkingmethod
https://www.cochrane.org/about-us/news/podcast-immunosuppressive-treatment-people-proliferative-lupus-nephritis
Podcast: Immunosuppressive treatment for people with proliferative lupus nephritis | Cochrane
treatment forlupus nephritispodcastimmunosuppressivepeople
https://bmcdev-e2b2a6gdfff3f6d0.uaenorth-01.azurewebsites.net/diseases/lupus-nephritis/
Lupus nephritis - Burjeel Medical City
lupus nephritismedicalcity
https://collections.nlm.nih.gov/catalog/nlm:nlmuid-9918680386806676-pdf
Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report - Digital...
lupus nephritisfinal reportbelimumabvoclosporin
https://health.economictimes.indiatimes.com/tag/lupus+nephritis
Lupus nephritis - Latest lupus nephritis , Information & Updates - Health -ET HealthWorld
ETHealthworld.com brings latest lupus nephritis news, views and updates from all top sources for the Indian Health industry.
lupus nephritislatest informationupdateshealthet
https://pmc.ncbi.nlm.nih.gov/articles/PMC11687987/
Antimalarials in Lupus Nephritis: How Strong Is the Evidence? - PMC
SLE is a chronic multisystem autoimmune disease that affects the kidneys in approximately 50% of patients, with the prevalence rising to as high as 70% in...
lupus nephritisthe evidenceantimalarialsstrongpmc
https://wexnermedical.osu.edu/departments/innovations/nephrology/lupus-nephritis-drugs
First drugs ever approved for lupus nephritis | Ohio State Medical Center
Investigators at The Ohio State Wexner Medical Center helped lead clinical trials that resulted in approval the first two drugs ever approved for lupus...
lupus nephritisohio statefirstdrugsever
https://data.mendeley.com/datasets/g57j2x8znc/1
Study of MicroRNA-124 in Patients with Lupus Nephritis - Mendeley Data
Study of MicroRNA-124 in Patients with Lupus Nephritis
in patientslupus nephritisstudymicrorna
https://mohanlab.bme.uh.edu/37-plex/
Spatial Proteomic, Transcriptomic, and Metabolomic Investigations of Lupus Nephritis | MOHAN LAB
lupus nephritisspatialproteomictranscriptomic
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1081942/full
Frontiers | Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement...
Objective: The pathogenesis of thrombotic microangiopathy (TMA) in lupus nephritis (LN) remains complicated. This study aimed to detect the deposition of com...
lupus nephritisfrontierspoor
https://www.cochrane.org/evidence/CD002922_immunosuppressive-treatment-people-proliferative-lupus-nephritis
Immunosuppressive treatment for people with proliferative lupus nephritis | Cochrane
treatment forlupus nephritisimmunosuppressivepeoplecochrane
https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis
Lupus & Kidney Disease (Lupus Nephritis) - NIDDK
Overview of lupus nephritis, a type of kidney disease caused by systemic lupus erythematosus, its complications, and how doctors diagnose and treat the disease.
kidney diseaselupusnephritis
https://lupusbmj.podbean.com/e/steroid-use-for-the-treatment-of-lupus-nephritis/
Steroid Use for the Treatment of Lupus Nephritis | Lupus Science and Medicine Podcast
Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg per kg prednisone)...
science and medicinesteroid usefor the
https://www.research.va.gov/about/funded_research/proj-details-FY2022.cfm?pid=743257
I01CX001248-05A2 - Targeting Pathogenic Endothelial Dysfunction in Lupus Nephritis
endothelial dysfunctiontargetingpathogeniclupusnephritis
https://mohanlab.bme.uh.edu/bruton-2/
Spatial Transcriptomics of Hypoxia and Immune-Mediated Damage in Lupus Nephritis | MOHAN LAB
https://pubmed.ncbi.nlm.nih.gov/21813587/
Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers
Anti-C1q performed the best of the potential biomarkers, being significantly associated with the modified SELENA-SLEDAI and with the Renal Activity Score. This...
https://pure.psu.edu/en/publications/experimental-anti-gbm-disease-as-a-tool-for-studying-spontaneous-/
Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis - Penn State
https://pubmed.ncbi.nlm.nih.gov/19369404/
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis
Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages over intravenous cyclophosphamide (IVC) for the treatment of lupus...
mycophenolate mofetilversuscyclophosphamideinductiontreatment
https://edoc.ub.uni-muenchen.de/10615/
Functional role of Toll-like receptor-7 in experimental lupus nephritis
functionalroletolllike
https://oru.diva-portal.org/smash/record.jsf?pid=diva2:1637429
Treat-to-Target in Lupus Nephritis : What is the Role of the Repeat Kidney Biopsy?
https://www.mdpi.com/2077-0383/11/11/3199
Serum and Urine Interferon Gamma-Induced Protein 10 (IP-10) Levels in Lupus Nephritis
Background: Lupus nephritis (LN) is a prevalent and severe complication of systemic lupus erythematosus (SLE). Non-invasive diagnostics are limited, and...
https://www.mdpi.com/2077-0383/11/11/2977
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric...
Background: The gold standard for diagnosis of lupus nephritis (LN) is still represented by renal biopsy, and serological prognostic biomarkers are still...
https://www.businesswire.com/news/home/20240501574612/en/Aurinia-Underscores-Enduring-Commitment-to-People-Living-with-Lupus-Nephritis-Through-Innovative-Advocacy-and-Education-Initiatives-for-Lupus-Awareness-Month
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative...
In recognition of Lupus Awareness Month, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced several initiatives to improve...
commitment to peopleliving with lupus